Legal & General Group PLC Ocular Therapeutix, Inc Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

A detailed history of Legal & General Group PLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Legal & General Group PLC holds 114,079 shares of OCUL stock, worth $962,826. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,079
Previous 114,079 -0.0%
Holding current value
$962,826
Previous $992,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$6.45 - $9.23 $31,888 - $45,633
4,944 Added 4.53%
114,079 $992,000
Q2 2024

Aug 14, 2024
BUY
$4.2 - $8.69 $407,488 - $843,112
97,021 Added 800.9%
109,135 $746,000
Q1 2024

May 14, 2024
BUY
$3.85 - $10.93 $14,017 - $39,796
3,641 Added 42.97%
12,114 $110,000
Q4 2023

Feb 15, 2024
SELL
$2.08 - $4.52 $906 - $1,970
-436 Reduced 4.89%
8,473 $37,000
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $2,276 - $3,654
-725 Reduced 7.53%
8,909 $27,000
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $1,499 - $2,490
326 Added 3.5%
9,634 $49,000
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $1,224 - $2,752
439 Added 4.95%
9,308 $49,000
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $1,562 - $2,483
-382 Reduced 4.13%
8,869 $37,000
Q2 2022

Aug 22, 2022
SELL
$3.01 - $5.22 $133,339 - $231,240
-44,299 Reduced 82.72%
9,251 $37,000
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $120,107 - $235,340
19,498 Added 57.26%
53,550 $374,000
Q3 2021

Nov 15, 2021
BUY
$9.7 - $14.34 $121,570 - $179,723
12,533 Added 58.24%
34,052 $341,000
Q2 2021

Aug 12, 2021
BUY
$13.43 - $19.16 $2,323 - $3,314
173 Added 0.81%
21,519 $305,000
Q1 2021

May 17, 2021
SELL
$15.82 - $22.11 $1,803 - $2,520
-114 Reduced 0.53%
21,346 $350,000
Q4 2020

Feb 12, 2021
BUY
$7.91 - $22.95 $112,662 - $326,876
14,243 Added 197.35%
21,460 $445,000
Q3 2020

Nov 13, 2020
SELL
$7.36 - $9.87 $9,104 - $12,209
-1,237 Reduced 14.63%
7,217 $55,000
Q2 2020

Aug 14, 2020
BUY
$4.67 - $8.95 $7,700 - $14,758
1,649 Added 24.23%
8,454 $70,000
Q1 2020

May 14, 2020
SELL
$3.95 - $7.4 $6,138 - $11,499
-1,554 Reduced 18.59%
6,805 $34,000
Q4 2019

Feb 13, 2020
BUY
$2.57 - $4.73 $4,322 - $7,955
1,682 Added 25.19%
8,359 $33,000
Q1 2019

May 15, 2019
BUY
$3.51 - $4.77 $6,440 - $8,752
1,835 Added 37.9%
6,677 $27,000
Q2 2018

Aug 10, 2018
SELL
$5.99 - $8.17 $1,443 - $1,968
-241 Reduced 4.74%
4,842 $33,000
Q1 2018

May 17, 2018
SELL
$4.66 - $7.08 $4,156 - $6,315
-892 Reduced 14.93%
5,083 $33,000
Q4 2017

Feb 13, 2018
BUY
$3.73 - $6.37 $22,286 - $38,060
5,975
5,975 $27,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $650M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email